Australia markets close in 3 hours 6 minutes

Myomo, Inc. (MYO)

NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
3.6200-0.3200 (-8.12%)
At close: 04:00PM EDT
3.8100 +0.19 (+5.25%)
After hours: 07:50PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close3.9400
Open3.9000
Bid3.6400 x 3000
Ask3.6400 x 1000
Day's range3.5500 - 3.9400
52-week range0.3710 - 5.5800
Volume208,202
Avg. volume279,268
Market cap104.254M
Beta (5Y monthly)1.53
PE ratio (TTM)N/A
EPS (TTM)-0.2800
Earnings date08 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.50
  • Business Wire

    Myomo Announces First Lump Sum Reimbursements for MyoPros Delivered to Medicare Part B Beneficiaries Under New CMS Fees

    BOSTON, May 06, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services ("CMS"), through their regional contractors known as the DME MACs, have remitted and paid lump sum reimbursements to the Company and are beginning to reimburse orthotics and prosthetics ("O&P") providers f

  • Business Wire

    Myomo to Report First Quarter Financial Results on May 8, 2024

    BOSTON, May 01, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the first quarter ended March 31, 2024 on May 8, 2024.

  • Business Wire

    Myomo Appoints Heather Getz to its Board of Directors

    BOSTON, March 28, 2024--Myomo, Inc. (NYSE American: MYO) ("Myomo" or the "Company"), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Heather Getz as a Class II director and chair of its audit committee effective March 26, 2024, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has seven directors.